Penn Science Policy and Diplomacy Group

By: Ian McLaughlin & Liana Vaccari References: Pipelines: https://primis.phmsa.dot.gov/comm/PipelineBasics.htm?nocache=2436 https://primis.phmsa.dot.gov/comm/construction/index.htm?nocache=7276 https://www.blm.gov/style/medialib/blm/wy/information/NEPA/cfodocs/greencore.Par.40103.File.dat/PODch3.pdf https://www.fractracker.org/2016/06/introduction-oil-gas-pipelines/ https://motherboard.vice.com/en_us/article/dakota-access-pipeline-is-back-on-skipping-environmental-review https://www.fws.gov/Midwest/endangered/permits/hcp/nisource/2013NOA/pdf/NiSourceHCPfinalAppndxJ_HDD.pdf https://daplpipelinefacts.com/ Science Budget: https://www.nigms.nih.gov/Research/CRCB/IDeA/Pages/default.aspx https://www.statnews.com/2017/03/28/budget-nih-cuts/ http://www.sciencemag.org/news/2017/03/trumps-first-budget-analysis-and-reaction https://www.axios.com/trump-proposal-would-slash-nih-funding-this-year-2333226759.html https://www.bloomberg.co...

by Adrian Rivera-Reyes and Koreana Pak Soft tissue sarcomas (STS) are rare cancers of the connective tissues, such as bone, muscle, fat, and blood vessels. Soft and elastic, sarcoma tumors can push against their surroundings as they grow silent and undetected. Residing in an arm, torso, or thigh, it can take years before a sarcoma begins to cause pain. By the time a patient presents their tumor to a doctor, amputation may be unavoidable 1 . In 2017, it is predicted that 12,390 Americans will be diagnosed with sarcoma, and approximately 5,000 patients will die from these tumors 2 . But the vast majority of these patients aren’t dying from the first tumor in their arm or leg—the real danger is metastasis, which is responsible for more than 90% of cancer-related deaths 3-5 . Metastasis occurs when tumor cells leave their original site and colonize a new area of the body, such as the lungs, liver, or bones 3-5 . The current treatment options for sarcoma—surgery, chemotherapy,...

Hosted By: Ian McLaughlin For more information about each of these two groups, please visit: GET-UP (pro graduate student union):  http://upenngetup.pa.aft.org/ Against this graduate student union effort:  https://nopennunion.org/

By: Ian McLaughlin & Enrique Lin Shiao

By: Ian McLaughlin & Liana Vaccari Antibiotic resistance, policy and prevention By: Liana Vaccari What are antibiotics? Antibiotics, which might also be called antimicrobial or antibacterial agents, are chemicals that can disrupt the life-cycle of bacteria in a few different ways; some actively kill the cells, others prevent them from reproducing, and others inhibit their ability to metabolize energy sources.  Over the years, they’ve been used for everything from strep throat to pneumonia 1 , but use has recently been dialed back because bacteria are becoming resistant to antibiotics that currently exist. One reason this has become an issue is that discoveries of new antibiotics can’t keep pace with the ability of the bacteria to resist old ones because developing new drugs is a long and expensive process. 2 , 3 Early this year, a woman died of an infection caused by a strain of bacteria that none of the 26 antibiotics available in America coul...

by Adrian Rivera-Reyes On November 10 th , the Penn Science Policy Group and the Penn Intellectual Property Group at Penn Law co-hosted a panel discussion focused on intellectual property and how to patent scientific research. The panel included Peter Cicala, Chief Patent Counsel at Celgene Corp.; Dr. Dora Mitchell, Director of the UPstart Program at the Penn Center for Innovation (PCI) Ventures; and Dr. Michael C. Milone, Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania (HUP), and Assistant Professor of Cell and Molecular Biology at Penn Medicine. The event started with the introduction of both groups by their respective presidents and was proceeded by Kimberly Li giving an introduction of the panelists. Next, Peter gave a short PowerPoint presentation with a general introduction of intellectual property. Below are some key points to understand intellectual property/patent law 1,2 : 1) In general, paten...